InsidersTradesSigma
Track the Lineage, Inc. stock price and the full insider trade history of the company, a listed issuer based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €2.3bn. The latest transaction was disclosed on 1 September 2026 (Acquisition). Among the most active insiders: Marchetti Kevin Patrick. All data is openly available.
75
Insider Decl.
n/a
Thresholds
€12m
19 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Lineage, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$62.05.
58Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,758 of 29,063 companies
19.6
score / 100
Value24
Quality15
FCF yld-3.8%
Earn yld-4.8%
EV/EBITDA·
ROE-40%
Gross mgn·
Net mgn-2.4%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 1 September 2026
Declarations75 total
25,000 shares@ US$39.50220.042% mcap17.1% of flowCommon StockSEC:0002021239-26-000006:0
Canonical exit: 26 Nov 2026 (T+90)
20,000 shares@ US$41.33190.038% mcap45.1% of flowCommon StockSEC:0001645808-26-000002:0
Canonical exit: 5 Nov 2026 (T+90)
4,490 sharesCommon StockSEC:0001684665-26-000005:0
4,490 sharesCommon StockSEC:0001628280-26-042562:0
205 shares@ US$35.550.0004% mcap32.9% of flowCommon StockSEC:0001820887-26-000006:0
13,118 shares0Common StockSEC:0001490473-26-000004:0
1,220 shares0Common StockSEC:0002094217-26-000004:0
12,203 shares0Common StockSEC:0001820887-26-000004:0
68,334 shares0Common StockSEC:0001748303-26-000004:0
20,745 shares0Common StockSEC:0002019216-26-000004:0
2,137 shares@ US$32.7633.2% of flowCommon StockSEC:0001490473-26-000004:1
1,516 shares@ US$32.76100.0% of flowCommon StockSEC:0002094217-26-000004:1
276 shares@ US$32.7629.1% of flowCommon StockSEC:0001820887-26-000004:1
8,422 shares@ US$32.76100.0% of flowCommon StockSEC:0001748303-26-000004:1
676 shares@ US$32.76100.0% of flowCommon StockSEC:0002018508-26-000004:0
13,300 shares@ US$37.496213.1% of flowCommon StockSEC:0002021239-26-000004:0
Canonical exit: 10 Jun 2026 (T+90)
11,222 shares@ US$39.05429.3% of flowCommon StockSEC:0002021239-26-000002:0
Canonical exit: 7 Jun 2026 (T+90)
616 shares0Common StockSEC:0002094217-26-000002:0
3,603 shares0Common StockSEC:0002019216-26-000002:0
4,258 shares0Common StockSEC:0002018599-26-000002:0
3,767 shares0Common StockSEC:0002018544-26-000002:0
5,405 shares0Common StockSEC:0002018532-26-000002:0
3,735 shares0Common StockSEC:0002018508-26-000002:0
1,049 shares0Common StockSEC:0001820887-26-000002:0
13,756 shares0Common StockSEC:0001748303-26-000002:0
25 of 75 declarations
关于 Lineage, Inc.
Lineage, Inc. 是一家在纳斯达克上市的公司，专注于为生物技术行业开发创新解决方案。它致力于研究和开发能够增进健康和福祉的产品。